Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.
about
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaNeoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy?Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.Neo adjuvant treatment with targeted molecules for renal cell cancer in current clinical practise.Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trialSunitinib for the management of advanced renal cell carcinoma.Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies.Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.Efficacy of pre-surgical axitinib for shrinkage of inferior vena cava thrombus in a patient with advanced renal cell carcinoma.
P2860
Q26749084-20345A67-EA8B-49A6-B920-53F1E54B5E66Q27002583-AF4A0620-5FFA-4042-9F90-B018E071FACDQ28087518-F931B889-6143-4F9C-9A16-8B218C18A5CFQ35916894-E80A73B4-1D5D-430A-B368-8FAB2A54AA5EQ36084067-31AFD0C3-58F2-4C29-9DAB-5A3D80C22CBEQ36338821-3BF1CACA-0590-4F87-8CCB-A10FF1A77D3DQ37705402-34A8517A-36AB-4844-9BC1-8274707837ACQ38005998-469CAE49-A846-458D-BC9E-32DCBBAECFD4Q38068585-9D0B2813-2FCD-4ED9-BEFC-2F227F0776F1Q38094592-1AB60073-DDE3-444A-B69D-45BE38EB5EFBQ38671842-01E618CE-176A-42A0-A956-C971AADA757DQ43182895-63785DB8-5B60-4C8E-8811-5AA42D23E722Q52884927-5F27EC3C-E5D4-4878-89DF-7F3D2AC1FE68Q54374819-022B792B-423F-4468-8BE4-27E4D241629B
P2860
Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@en
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@nl
type
label
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@en
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@nl
prefLabel
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@en
Case study of the month. Compl ...... y in T3b renal cell carcinoma.
@nl
P2093
P50
P1433
P1476
Case study of the month. Compl ...... py in T3b renal cell carcinoma
@en
P2093
Colette Deminière
Grégoire Gabbay
Grégoire Robert
Hervé Wallerand
Philippe Ballanger
Raphaël Bram
P304
P356
10.1016/J.EURURO.2008.12.036
P407
P577
2009-01-09T00:00:00Z